11-Sept-2026 19:44:44
JUBLPHARMAGeneral news
JUBILANT PHARMOVA : USFDA DETERMINES VOLUNTARY ACTION INDICATED FOR CMO FACILITY AT SPOKANE, WA, U.S.A
• USFDA has concluded its review of the Establishment Inspection Report (EIR) for the inspection conducted at Jubilant HollisterStier LLC's CMO facility in Spokane, Washington, USA. • The facility has been classified as "Voluntary Action Indicated (VAI)". • Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of Jubilant Pharmova Limited.
Jubilant Pharmova Ltd
Open attachment